Pancreatic Cancer Research

ResearcherParkview HealthActive in the last 2 years

Neil R Sharma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6248-2445; OpenAlex author ID A5025987886. Sources: ClinicalTrials.gov.

Their work

Papers
6 (first author 1, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2014: 1 paper · 2015: 1 trial · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 3 papers · 2024: 1 paper

Papers 6

  1. Endoscopic Ultrasound-Guided Treatments for Pancreatic Cancer: Understanding How Endoscopic Ultrasound Has Revolutionized Management of Pancreatic Cancer. Co-author DOI 10.3390/cancers17010089↗
  2. Does acute pancreatitis herald pancreatic ductal adenocarcinoma? A multicenter electronic health research network study. Co-author DOI 10.1002/cam4.5094↗
  3. Response of Locally Advanced Pancreatic Cancer to Intratumoral Injection of Large Surface Area Microparticle Paclitaxel: Initial Report of Safety and Clinical … Co-author DOI 10.1097/mpa.0000000000002236↗
  4. Role of Therapeutic Endoscopic Ultrasound in Management of Pancreatic Cancer: An Endoscopic Oncologist Perspective. Last author DOI 10.3390/cancers15123235↗
  5. Artificial Intelligence in Endoscopic Ultrasound for Pancreatic Cancer: Where Are We Now and What Does the Future Entail? Last author DOI 10.3390/jcm11247476↗
  6. MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic cancer. First author DOI 10.1158/1078-0432.ccr-13-2174↗

Trials 1

  1. Comparison Study in Pancreatic Fiducial Placement Principal investigator NCT02376543↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dushyant Singh Dahiya · 3 shared papers, 2022–2024 · strength 0.54
  2. Saurabh Chandan · 2 shared papers, 2022–2023 · strength 0.32
  3. Andrew Canakis · 2 shared papers, 2022–2023 · strength 0.32
  4. Mohammad Al‐Haddad · 2 shared papers, 2022–2023 · strength 0.32
  5. Eileen Mary O'Reilly · 1 shared paper, 2023 · strength 0.26
  6. Ritu Singh · 1 shared paper, 2023 · strength 0.26
  7. Alison P. Klein · 1 shared paper, 2023 · strength 0.26
  8. Sahib T Singh · 1 shared paper, 2024 · strength 0.23
  9. Antonio Facciorusso · 1 shared paper, 2024 · strength 0.23
  10. Sudhir Dutta · 1 shared paper, 2024 · strength 0.23
  11. Sumant Inamdar · 1 shared paper, 2024 · strength 0.23
  12. Hassam Ali · 1 shared paper, 2023 · strength 0.17
  13. Simon K. Lo · 1 shared paper, 2023 · strength 0.16
  14. Andrew Eugene Hendifar · 1 shared paper, 2023 · strength 0.16
  15. Gere S. diZerega · 1 shared paper, 2023 · strength 0.16
  16. Mohamed O. Othman · 1 shared paper, 2023 · strength 0.16
  17. Christian Max Schmidt · 1 shared paper, 2023 · strength 0.16
  18. Daryl Ramai · 1 shared paper, 2022 · strength 0.15
  19. Lynette M. Smith · 1 shared paper, 2014 · strength 0.04
  20. Imayavaramban Lakshmanan · 1 shared paper, 2014 · strength 0.04
  21. Subodh M. Lele · 1 shared paper, 2014 · strength 0.04
  22. Michael Anthony Hollingsworth · 1 shared paper, 2014 · strength 0.04
  23. Surinder K. Batra · 1 shared paper, 2014 · strength 0.04
  24. Sushovan Guha · 1 shared paper, 2014 · strength 0.04
  25. Sukhwinder Kaur · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.